NCT05469503

Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure

A Randomized, Placebo-controlled, Double-blind Study to Assess the Effect of TOTUM-854 on Blood Pressure in Subjects With Moderately Elevated Blood Pressure

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 410 (actual)
• Sponsor: Valbiotis · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This clinical study aims to assess the efficacy of TOTUM-854, a mix of 6 plant extracts, consumed twice a day on automated office blood pressure in subjects with moderately elevated blood pressure. The hypothesis is that TOTUM-854 is superior to placebo for decrease of automated office blood pressure after 12 weeks of consumption.

Conditions

• Prehypertension
• Elevated Blood Pressure
• Blood Pressure
• Metabolic Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	TOTUM-854	12 weeks of TOTUM-854 supplementation
DIETARY_SUPPLEMENT	Placebo	12 weeks of placebo supplementation

Timeline

• Start date: 2022-07-15
• Primary completion: 2024-09-01
• Completion: 2024-12-01
• First posted: 2022-07-21
• Last updated: 2024-04-23

Locations

10 sites across 3 countries: Bulgaria, France, Poland